Anti-Clotting Drug Trial Shortened by Bleedin... ( But study author says medication coul...)

Anti-Clotting Drug Trial Shortened by Bleeding Problems

Date:1/24/2008

But study author says medication could help many avoid stroke

THURSDAY, Jan. 24 (HealthDay News) -- A study of the new anti-clotting drug idraparinux for preventing strokes was stopped early because of excess bleeding, a problem that has plagued the medication.

But the researchers said the trial could open the way to at least limited use of the drug.

The bleeding problem seems to occur primarily in two groups of people -- those over 70 and those with kidney impairment, said study lead author Dr. Harry R. Buller, chairman of the department of vascular medicine at the Academic Medical Center in Amsterdam, the Netherlands.

"We have started a new study in which we have adapted the dose for persons with renal [kidney] impairment," Buller said. "This is another chance to show that this concept is alive."

Idraparinux is one of a number of anti-clotting agents being tested as possible replacements for the current standby warfarin (Coumadin), which is highly effective but difficult to manage, requiring frequent blood tests.

Buller is an idraparinux enthusiast. "Its beauty is twofold," he said. "It uses the body's natural defenses, and it can be given once a week. But much to our regret, particularly in persons over 70 or with some kind of renal impairment, the concentration of the drug builds up, and there is excessive bleeding."

The new study was stopped after enrollment of 4,576 people with atrial fibrillation -- an irregular heartbeat -- after excess bleeding occurred in 19.7 percent of those given weekly injections of idraparinux, compared to 11.3 percent of those taking other anti-clotting agents.

The findings were published in the Jan. 26 issue of The Lancet.

To outside observers, that was a depressing repeat of studies, reported last September, that showed the drug to be effective against deep vein thrombosis and long-term prevention of blood clots but with a h
'/>"/>

1

GOOD

Page: 1 2
Related medicine news :

1. Possible safer target for anti-clotting drugs found
2. New Anti-Clotting Drug Shows Promise in Heart Patients
3. Researchers identify molecules with interesting anti-clotting properties
4. New Heart Pump Shows Promise in Trial
5. Trial to Test Gene Therapy for Angina in Women
6. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
7. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. MDS Pharma Services Wins Award for Management of Global Malaria Trial
10. New Ovarian Cancer Drug Trial Under Way
11. Study Questions Dead-End Cancer Clinical Trials

Post Your Comments:

Related Image:

Anti-Clotting Drug Trial Shortened by Bleeding Problems

(Date:5/19/2013)... May 19, 2013 6Webs.com is the ... companies. Homeowners who are considering an alarm system can ... the nation's leading security system providers online at 6Webs.com. ... best DIY home security system companies, 6Webs.com ... reviews dozens of home security companies before ranking the ...

(Date:5/19/2013)... Seattle, Wa (PRWEB) May 19, 2013 ... new fat loss program that provides people with ... instructions. When people order this Fat Burning Furnace package, ... other materials that they can download quickly. The Fat ... information that helps people build lean muscle mass. In ...

(Date:5/19/2013)... 2013 Farming methods have changed many ... ground 10,000 years ago. Most recently, the Green Revolution ... using genetically engineered seeds and by applying chemical fertilizers ... to these techniques due to the adverse environmental and ... corresponding surge in interest in organic, sustainable farming practices ...

(Date:5/19/2013)... 2013 Vegas Hotel Escapes, the premier ... announce the launch it's all new vacation packages for ... on 5/19/2013. Consumers traveling to Las Vegas will be ... on VegasHotelEscapes.com's website. Travelers will be pleased to know ... price. , Vegas Hotel Escapes specializes in helping consumers ...

(Date:5/19/2013)... 2013 Exciting new Skin Brushes are ... a great practice known through the ages but is ... dry body brushing, has so many benefits for our ... Beauty®. "We love that circulation and lymphatic systems get ... the skin, is supported through Skin Brushing." , Why ...

Breaking Medicine News(10 mins):Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2 Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3 Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2

[0] Top Rated DIY Home Security System Companies Published by 6Webs.com [0] Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool [0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret

... Consulting firm, a new white paper reveals how small businesses benefit from ... ... 30, 2009 -- Due to a grim economic forecast for 2009, businesses ... their recession woes. This is according to a new white paper recently ...

... of Dimes Awards Abstract at SMFM Meeting. SAN ... explain why taking progesterone to prevent preterm birth ... today at the 29th Annual Society for Maternal-Fetal ... 17 alpha-hydroxyprogesterone caproate (or 17P), a synthetic form ...

... at the American,Academy of Pain Medicine,s 25th Annual Meeting ... public perceptions about their,safety and patient non-compliance in the ... studies at this year,s meeting illuminate the issues faced ... treatments. Two studies,highlight some of the most important ...

... Medical Innovations, Inc. (NYSE: IMA ), a ... solutions, announced today that it will attend the 2009 ... through 11, 2009 at the Waldorf Astoria in New ... attend, as will Jon Russell, Vice President of Finance, ...

... CITY, Calif., Jan. 29 Abaxis, Inc.,(Nasdaq: ABAX ), ... results for the fiscal quarter,ended December 31, 2008. , , ... * Revenues of $27.0 million, up 5% ... market sales of $7.2 million, up 19% over last year,s, ...

... a number of leading health organizations, including Sermo, ... PreventionNEW YORK, Jan. 29 Envision Solutions, LLC, ... publication of a new report, "Achieving Openness: The ... Using Social Networks for Health and Wellness." ...

CPEhr Releases New White Paper Highlighting Value of Human Resources Outsourcing In A Recession Effectiveness of Progesterone in Reducing Preterm Births May Be Altered by Genetic Predisposition Under-Treatment of Pain Exacerbated by Public Perceptions of Medicines and Safety Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009 Abaxis Reports Financial Performance for the Third Quarter of Fiscal 2009 New Report Teaches The Art Of Communicating With People Using Social Networks For Health & Wellness

(Date:5/17/2013)... , May 17, 2013 PENTAX Medical, ... Hitachi-Aloka Medical, a global leader in ultrasound imaging, ... global companies to enable further innovation in the ... the Hitachi-Aloka ultrasound systems and PENTAX Medical endoscopic ... trusted families of EUS systems. This agreement will ...

(Date:5/17/2013)... NATICK, Mass. , May 17, 2013 Boston ... to participate at the annual EuroPCR Scientific Program May ... "We are pleased to present a particularly rich and ... Keith Dawkins , M.D., global chief ... several trials will be presented, including the NG PROMUS ...

(Date:5/16/2013)... May 16, 2013 Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...

Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2 PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7 Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2 National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3

[0] PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems [0] Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 [0] National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill

... Gamma Pharmaceuticals, Inc. (PINKSHEETS: GMPM.PK) a marketing and ... for everyday health and wellness, announced this afternoon, ... Order for the Company,s 17-gram Gamma Energy GEL. ... value. Gamma will support sales with point of ...

... Cerecor Inc. , a biopharmaceutical company focused on ... primary activity is in the human nervous system, today ... FP01 for the treatment of cough has cleared the ... Drug Administration (FDA). The Company plans to immediately characterize ...

Cached Medicine Technology:Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 2 Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™ 3 Cerecor Announces Clearance of IND for FP01 2

Gamma Pharmaceuticals, Inc. Announces Distribution Agreement for New York Tri-state Area and Purchase Order for Gamma Energy GEL™Cerecor Announces Clearance of IND for FP01

Standard bipolar coagulator...

...

Medicine Products:

Elmed BC 50 Standard Hudson-Downs Burr McKenzie Perforator Drill Cushing Perforator Drill